Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
David Rakel MD, FAAFP
David Rakel MD, FAAFP Editor-in-Chief
See All Experts
story of the week
Published in Primary Care and
1 other channel

Journal Scan / Research · November 01, 2022

Aspirin for Primary Prevention of CV Events in Relation to Lp(a) Genotypes

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Journal of the American College of Cardiology
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
J Am Coll Cardiol 2022 Oct 04;80(14)1287-1298, P Lacaze, A Bakshi, M Riaz, G Polekhina, A Owen, HS Bhatia, P Natarajan, R Wolfe, L Beilin, SJ Nicholls, GF Watts, JJ McNeil, AM Tonkin, S Tsimikas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated